when fda approve intellia therapeutics' lonvo-z
Before July 2027
when fda approve intellia therapeutics' lonvo-z. Best Yes near 37¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 37¢ · Best No: 73¢ · 1 platform
- Kalshi: Yes 37¢ / No 73¢
LIVE
Before July 2027
Volume
$1.6K
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jul 1, 2027
~380 days left
Category
Culture
Yes
37¢
Kalshi
No
73¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jul 1, 2027
Time Left380 days
Status● Active
CategoryCulture
Yes
37¢
Kalshi
Payout 2.7x
No
73¢
Kalshi
Payout 1.4x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In